Stock comparison
Innoviva
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
INVA
Innoviva
Market cap
$1.66B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | INVA | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 51C | 69B | MTD |
| Benjamin Graham | 50C | 65B | MTD |
| Philip Fisher | 44D | 63C | MTD |
| Peter Lynch | 16F | 66B | MTD |
| Joel Greenblatt | 32F | 68B | MTD |
| Charlie Munger | 47D | 74B | MTD |
| Terry Smith | 46D | 70B | MTD |
Side-by-side metrics
| Metric | INVA | MTD |
|---|---|---|
| Market cap | $1.66B | $22.29B |
| P/E (TTM) | 3.3x | 25.3x |
| EV/EBIT | 8.6x | 21.6x |
| ROIC (TTM) | 2.93% | 36.09% |
| Gross margin | 76.2% | 57.79% |
| Net margin | 118.91% | 21.4% |
| Revenue CAGR 5y | 2.06% | 2.01% |
| EPS CAGR 5y | 5.54% | 6.12% |
| Debt / Equity | 0.2x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
INVA leads on
- P/E (TTM)3.3xvs 25.3x+87%
- Net margin118.91%vs 21.4%+82%
- EV/EBIT8.6xvs 21.6x+60%
- Gross margin76.2%vs 57.79%+24%
MTD leads on
- Debt / Equity-vs 0.2x+100%
- Market cap$22.29Bvs $1.66B+93%
- ROIC (TTM)36.09%vs 2.93%+92%
- EPS CAGR 5y6.12%vs 5.54%+9%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.